Portfolio news 0

Tissue Regenix Group plc

Tissue Regenix Group plc - Interim results for the six months ended 30 June 2024

Oxford Nanopore Technologies Plc

Oxford Nanopore seeks discovery in connection with anticipated breach of contract action

Microbiotica Ltd

Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies

Oxa

Oxa - Third Commercial Deployment of Oxa's Self-driving Software in the United States, in Collaboration With Beep

MoA Technology Ltd

Moa announces international field trial success at the ACS autumn conference in Denver

Featurespace Limited

PAYSTRAX has selected Featurespace to tackle fraud across Europe, demonstrating the strength of their fraud prevention technology

Oxford Nanopore Technologies Plc

Oxford Nanopore attracts investment from Novo Holdings and completes Equity Issue of £80 million

First Light Fusion Ltd

First Light Fusion partners with leading European institutions in support of Magnetic Confinement Fusion research

First Light Fusion Ltd

First Light Fusion hosts Japanese Government delegation at Oxford HQ

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Half Year Trading Update